alpha/beta-blockade versus beta blockade essential hypertension black white patients purpose multicenter investigation efficacy safety alpha/beta-blocker labetalol beta beta-blocker atenolol white black patients essential hypertension Equal numbers black white patients treatment groups white patients labetalol atenolol black patients labetalol atenolol ninety-two patients white black patients essential hypertension diastolic blood pressure mm Hg inclusive trial Patients labetalol dosage mg/day atenolol dosage mg/day therapeutic goal achievement diastolic blood pressure mm Hg fall mm Hg diastolic pressure baseline value end placebo run period end study significant differences blood pressure heart rate changes supine position labetalol atenolol groups contrast labetalol reduction standing systolic diastolic blood pressure mm Hg atenolol mm Hg decrease blood pressure white patients labetalol black patients decrease blood pressure labetalol atenolol respect systolic blood pressure alpha property labetalol additional lowering blood pressure beta standing position enhanced efficacy radical group 